2023 drug approvals: After a down year, FDA signs off on a bounty of new meds, including 7 from Pfizer

In 2022, fueled by its powerhouse COVID products, Pfizer became the first company in the history of the biopharma industry to top $100 billion in annual revenue. What would the New York drugmaker do for an encore?In 2023, Pfizer went from generating the most sales in the industry to gaining the most approvals.With seven FDA […]